Vous êtes sur la page 1sur 4

Luminescent biosensors for real-time monitoring of intracellular cAMP.

Binkowski BF, Fan F, Wood KV. Source


Promega Corporation, Madison, WI, USA. brock.binkowski@promega.com

Abstract
G-protein coupled, seven-transmembrane (7-TM) receptors (GPCRs) comprise a diverse class of signaling molecules involved in cellular physiology and pathology. In recent years, intracellular biosensors have been developed to monitor changes in intracellular cAMP in real time, facilitating studies on the mechanisms of GPCR activation and desensitization in living cells. However, methods based on fluorescence can show limitations in response dynamics together with being difficult to perform. Here we present the use of genetically encoded, luminescent biosensors that allow a facile, non-lytic assay format for monitoring cAMP dynamics in living cells.

Nanowire biosensors for label-free, real-time, ultrasensitive protein detection.


Zheng G, Lieber CM. Source
Laboratory of Advanced Materials, Department of Chemistry, Fudan University, Shanghai, China. gfzheng@fudan.edu.cn

Abstract
Sensitive and quantitative analysis of proteins is central to disease diagnosis, drug screening, and proteomic studies. Among recent research advances exploiting new nanomaterials for biomolecule analysis, silicon nanowires (SiNWs), which are configured as field-effect transistors (FETs), have emerged as one of the most promising and powerful platforms for label-free, real-time, and highly sensitive electrical detection of proteins as well as many other biological species. Here, we describe a detailed protocol for realizing SiNW biosensors for protein detection that includes SiNW synthesis, FET device fabrication, surface receptor functionalization, and electrical sensing measurements. Moreover, incorporating both p-type and n-type SiNWs in the same sensor array provides a unique means of internal control for sensing signal verification.

Near real-time, on-site, quantitative analysis of PAHs in the aqueous environment using an antibody-based biosensorKeywords:

Biosensor; PAH; Immunoassay; Monoclonal antibodies; Real-time monitoring

Abstract
Rapid, on-site, quantitative assessments of dissolved polycyclic aromatic hydrocarbons (PAHs) were demonstrated for two field applications. The platform, a KinExA Inline Sensor (Sapidyne Instruments), employed the monoclonal anti-PAH antibody, 7B2.3, which has specificity for 3- to 5-ring PAHs. A spatial study was conducted near a dredging

site where contaminated sediments were being removed, and a temporal study was performed during a rainfall event. Most importantly, the generation of near real-time data guided management decisions in the field and determined proper sampling protocols for conventional analyses. The method was able to determine PAH concentrations as low as 0.3g/L, within 10min of sample acquisiti on, and to assess 80+ samples (not including standards and blanks) in less than 3 d. These results were compared with a laboratory-based gas chromatographymass spectrometry method in which a wide array of PAHs, including alkylated homologs, were examined. This system shows great promise as a field instrument for the rapid monitoring of PAH pollution. Environ. Toxicol. Chem. 2011; 30:1557 1563. 2011 SETAC

A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging


Sang Bok Kim , Hojae Bae , Jae Min Cha , Sang Jun Moon , Mehmet R. Dokmeci , Donald M. Cropek and Ali Khademhosseini Lab Chip, 2011, 11, 1801-1807 DOI: 10.1039/C1LC20098D Received 03 Feb 2011, Accepted 23 Mar 2011 First published on the web 11 Apr 2011 Share||||||

PDF Rich HTML Buy PDF (34) Download Citation

Request Permissions Please choose one of the options provided in the log in section to gain access to this content:
Abstract Cited by Compounds Related Content

A portable and cost-effective real-time cardiotoxicity biosensor was developed using a CMOS imaging module extracted from a commercially available webcam. The detection system consists of a CMOS imaging module, a white LED and a pinhole. Real-time image processing was conducted by comparing reference and live frame images. To evaluate the engineered system, the effects of two different drugs, isoprenaline and doxorubicin, on the beating rate and beat-to-beat variations of ESC-derived cardiomyocytes were measured. The detection system was used to conclude that the beat-to-beat variability increased under treatment with bothisoprenaline and doxorubicin. However,

the beating rates increased upon the addition ofisoprenaline but decreased for cultures supplemented with doxorubicin. Moreover, the response time for both the beating rates and the beat-to-beat variability of ESCderivedcardiomyocytes under treatment of isoprenaline was shorter than for doxorubicin, although the amount of isoprenaline used in the measurement was three orders of magnitude lower than that of doxorubicin. Given its ability to perform real-time cell monitoring in a simple and inexpensive manner, the proposed system may be useful for a range of cell-based biosensing applications.

Webcam measures medications effects on heart


Compiled by BioPhotonics staff BOSTON A tool using basic webcam technology enables real-time study of medications effects on heart cells called cardiomyocytes including any drug-induced changes in the beating rate. The technology could help drug makers and prescribers address a side effect of drugs called cardiotoxicity an unhealthy change in the way the heart beats. Scientists at Brigham and Womens Hospital (BWH) have developed a cost-effective, portable cellbased biosensor for real-time cardiotoxicity detection using an image sensor from a basic webcam. Using the biosensor to monitor the beating rates and to detect any drug-induced changes, they introduced various drugs to cardiomyocytes derived from mouse stem cells.

Using an image sensor from a basic webcam, scientists at Brigham and Womens Hospital have developed a portable cell-based biosensor for real-time detection of cardiotoxicity. The new technique provides a simple approach to performing evaluative studies of different drugs effects on cardiac cells. Assessing the toxic effects of new drugs during the early phases of drug development can accelerate the drug discovery process, resulting in significant cost and time savings, and leading to faster treatment discovery, said Ali Khadem-hosseini, PhD, of the Center for Biomedical Engineering at the Department of Medicine at BWH. In addition, the technology could play a role in personalized medicine. The biosensor could be used to monitor cardiac cells that have been introduced to medication, providing a glimpse of how the drug affects the individuals heart, which could help doctors shape the treatment plan for that patient. The researchers hope to combine the detection system with their microwell arrays to screen thousands of drugs simultaneously in a fast, reliable manner, Khademhosseini said.

ARTICLE DISCUSSION